UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

European journal of cancer (1990), 1994, Vol.30 (11), p.1714-1721

1994

Volltextzugriff (PDF)

IV.7 Tamoxifen and uterine cancer: Confounding variables

European journal of cancer (1990), 1998, Vol.34, p.S50-S51

Jordan, V.C.

1998

Volltextzugriff (PDF)

Gynecologic effects of tamoxifen and the association with endometrial carcinoma

International Journal of Gynecology and Obstetrics, 1995-06, Vol.49 (3), p.241-257

1995

Volltextzugriff (PDF)

Tamoxifen for Breast Cancer Prevention

Experimental biology and medicine (Maywood, N.J.), 1995-02, Vol.208 (2), p.144-149

Jordan, V. Craig

1995

Volltextzugriff (PDF)

Changing role of the oestrogen receptor in the life and death of breast cancer cells

Breast (Edinburgh), 2003-12, Vol.12 (6), p.432-441

2003

Volltextzugriff (PDF)

Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue

Cancer letters, 1995-05, Vol.92 (1), p.39-47

1995

Volltextzugriff (PDF)

Oestrogen receptors, growth factors and the control of breast cancer

Breast (Edinburgh), 2001-08, Vol.10, p.27-35

Jordan, V.C.

2001

Volltextzugriff (PDF)

Oestrogens, Oestrogen Receptors and Breast Cancer

European journal of cancer supplements, 2003-09, Vol.1 (1), p.1-12

2003

Volltextzugriff (PDF)

V.3 Is there life after tamoxifen? New anti-oestrogens

European journal of cancer (1990), 1998, Vol.34, p.S57-S58

1998

Volltextzugriff (PDF)

Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats

Carcinogenesis (New York), 1995-11, Vol.16 (11), p.2733-2741

1995

Volltextzugriff (PDF)

Tamoxifen in liver disease: Potential exacerbation of hepatic dysfunction

Annals of oncology, 1998-10, Vol.9 (10), p.1123-1126

1998

Volltextzugriff (PDF)

The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis

Carcinogenesis (New York), 1996-03, Vol.17 (3), p.585-594

1996

Volltextzugriff (PDF)

Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss

European journal of cancer (1990), 1994, Vol.30A (10), p.1559-1564

1994

Volltextzugriff (PDF)

Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats

Carcinogenesis (New York), 1996-05, Vol.17 (5), p.1051-1056

1996

Volltextzugriff (PDF)

8.08 - Tamoxifen

Comprehensive Medicinal Chemistry II, 2007, Vol.8, p.83-102

Jordan, V.C.

Second Edition, 2007

Volltextzugriff (PDF)

HEALTH AND SAFETY INSPECTIONS

The Lancet (British edition), 1977-12, Vol.310 (8049), p.1174-1174

Jordan, V.C.

1977

Volltextzugriff (PDF)

Effect of Chronic Administration of Mestranol, Tamoxifen, and Toremifene on Hepatic Ploidy in Rats

Toxicological sciences, 1998-06, Vol.43 (2), p.129-138

1998

Volltextzugriff (PDF)

TAMOXIFEN PROPHYLAXIS

The Lancet (British edition), 1986, Vol.327 (8472), p.105-105

Jordan, V.C.

1986

Volltextzugriff (PDF)

The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells

Cancer letters, 1995-03, Vol.90 (1), p.35-42

1995

Volltextzugriff (PDF)

Prelude to breast cancer prevention with an antiestrogen

Annals of oncology, 1990-09, Vol.1 (5), p.327-328

Jordan, V C

1990

Volltextzugriff (PDF)

Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA -induced rat mammary carcinoma model

European journal of cancer, 1980-02, Vol.16 (2), p.239-251

1980

Volltextzugriff (PDF)

Prolonged adjuvant tamoxifen: A beginning not the end

Annals of oncology, 1991-07, Vol.2 (7), p.481-484

Jordan, V C

1991

Volltextzugriff (PDF)

Tamoxifen: From breast cancer therapy to the design of a postmenopausal prevention maintenance therapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 1997, Vol.9 (6), p.390-394

1997

Volltextzugriff (PDF)

Metabolism of steroid-modifying anticancer agents

Pharmacology & therapeutics (Oxford), 1988, Vol.36 (1), p.41-103

1988

Volltextzugriff (PDF)

A study of the oestrogenic and anti-oestrogenic activities of some substituted triphenylethylenes and triphenylethanes

Jordan, V.C

1972

Volltextzugriff (PDF)

26 – 50 von 96

Menü

Weitere Dienste

Einstellungen

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

IV.7 Tamoxifen and uterine cancer: Confounding variables

Gynecologic effects of tamoxifen and the association with endometrial carcinoma

Tamoxifen for Breast Cancer Prevention

Changing role of the oestrogen receptor in the life and death of breast cancer cells

Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue

Oestrogen receptors, growth factors and the control of breast cancer

Oestrogens, Oestrogen Receptors and Breast Cancer

V.3 Is there life after tamoxifen? New anti-oestrogens

Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats

Tamoxifen in liver disease: Potential exacerbation of hepatic dysfunction

The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis

Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss

Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats

8.08 - Tamoxifen

HEALTH AND SAFETY INSPECTIONS

Effect of Chronic Administration of Mestranol, Tamoxifen, and Toremifene on Hepatic Ploidy in Rats

TAMOXIFEN PROPHYLAXIS

The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells

Prelude to breast cancer prevention with an antiestrogen

Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA -induced rat mammary carcinoma model

Prolonged adjuvant tamoxifen: A beginning not the end

Tamoxifen: From breast cancer therapy to the design of a postmenopausal prevention maintenance therapy

Metabolism of steroid-modifying anticancer agents

A study of the oestrogenic and anti-oestrogenic activities of some substituted triphenylethylenes and triphenylethanes

Suchergebnisse filtern